Overexpression of Apolipoprotein A-I Alleviates Insulin Resistance in MASLD Mice Through the PPARα Pathway
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26031051 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yifan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Municipal Laboratory for Liver Protection and Regulation of Regeneration, Department of Cell Biology, School of Basic Medical Sciences, Capital Medic…. Hauptthemen laut MEDLINE: Insulin Resistance, PPAR alpha, Apolipoprotein A-I, Fatty Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, R&D Program of Beijing Municipal Education Commission, R&D Program of Beijing Municipal Education Commission.
Abstract (Originalsprache)
Insulin resistance (IR) is one of the important causes of metabolic dysfunction-associated steatotic liver disease (MASLD). Apolipoprotein A-I (apoA-I) is secreted primarily by hepatocytes and plays an essential role in reverse cholesterol transport. Our previous studies revealed that apoA-I can mitigate the progression of metabolic dysfunction-associated steatohepatitis (MASH). However, there is no clear evidence to explain the relationship between apoA-I and IR. Here, we investigated the effects of apoA-I overexpression on IR in both HepG2 cells and mice. In vitro experiment results revealed that apoA-I overexpression can promote cellular glucose uptake in oleic acid-induced IR in HepG2 cells. High-fat, high-cholesterol, and high-fructose diets were used to induce IR in mice. The results showed that apoA-I overexpression improved glucose tolerance, reduced serum insulin levels, and ameliorated IR in diet-induced MASLD mice. Moreover, apoA-I promoted the expression of peroxisome proliferator-activated receptor α (PPARα) in the nucleus both in vitro and in vivo. In conclusion, apoA-I could alleviate MASLD by reducing IR in mice and might exert this effect through the PPARα pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Municipal Laboratory for Liver Protection and Regulation of Regeneration, Department of Cell Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
ORCID-Profile: Yudian Zhang
Förderung
- National Natural Science Foundation of China
- R&D Program of Beijing Municipal Education Commission
- R&D Program of Beijing Municipal Education Commission
Zitieren
APA
Wang, Y., Zhang, Y., & Wang, Y. (2025). Overexpression of Apolipoprotein A-I Alleviates Insulin Resistance in MASLD Mice Through the PPARα Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031051
Vancouver
Wang Y, Zhang Y, Wang Y. Overexpression of Apolipoprotein A-I Alleviates Insulin Resistance in MASLD Mice Through the PPARα Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031051
BibTeX
@article{Wang2025,
author = {Wang, Yifan and Zhang, Yudian and Wang, Yutong},
title = {Overexpression of Apolipoprotein A-I Alleviates Insulin Resistance in MASLD Mice Through the PPARα Pathway},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031051}
}
EUVIMED